title: Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays.
abstract: Translocation of TMPRSS2 to the ERG gene, found in a high proportion of human prostate cancer, results in overexpression of the 3'-ERG sequences joined to the 5'-TMPRSS2 promoter. The studies presented here were designed to test the ability of expression analysis on GeneChip Human Exon 1.0 ST arrays to detect 5'-TMPRSS2-ERG-3' hybrid transcripts encoded by this translocation. Monitoring the relative expression of each ERG exon revealed altered transcription of the ERG gene in 15 of a series of 27 prostate cancer samples. In all cases, exons 4 to 11 exhibited enhanced expression compared with exons 2 and 3. This pattern of expression indicated that the most abundant hybrid transcripts involve fusions to ERG exon 4, and RT-PCR analyses confirmed the joining of TMPRSS2 exon 1 to ERG exon 4 in all 15 cases. The exon expression patterns also indicated that TMPRSS2-ERG fusion transcripts commonly contain deletion of ERG exon 8. Analysis of gene-level data from the arrays allowed the identification of genes whose expression levels significantly correlated with the presence of the translocation. These studies demonstrate that expression analyses using exon arrays represent a valuable approach for detecting ETS gene translocation in prostate cancer, in parallel with analyses of gene expression profiles.
authors.affiliation: Institute of Cancer Research, Male Urological Cancer Research Centre, Sutton, Surrey SM2 5NG, UK.
authors.forename: Sameer
authors.initials: S
authors.lastname: Jhavar
authors.forename: Alison
authors.initials: A
authors.lastname: Reid
authors.forename: Jeremy
authors.initials: J
authors.lastname: Clark
authors.forename: Zsofia
authors.initials: Z
authors.lastname: Kote-Jarai
authors.forename: Timothy
authors.initials: T
authors.lastname: Christmas
authors.forename: Alan
authors.initials: A
authors.lastname: Thompson
authors.forename: Christopher
authors.initials: C
authors.lastname: Woodhouse
authors.forename: Christopher
authors.initials: C
authors.lastname: Ogden
authors.forename: Cyril
authors.initials: C
authors.lastname: Fisher
authors.forename: Cathy
authors.initials: C
authors.lastname: Corbishley
authors.forename: Johann
authors.initials: J
authors.lastname: De-Bono
authors.forename: Rosalind
authors.initials: R
authors.lastname: Eeles
authors.forename: Daniel
authors.initials: D
authors.lastname: Brewer
authors.forename: Colin
authors.initials: C
authors.lastname: Cooper
mesh_terms: D004268:DNA-Binding Proteins / Q000235:genetics; D005091:Exons / Q000235:genetics*; D020869:Gene Expression Profiling / Q000379:methods*; D015972:Gene Expression Regulation, Neoplastic; D052138:Genes, Neoplasm; D006801:Humans; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015534:Trans-Activators / Q000235:genetics; D000071230:Transcriptional Regulator ERG; D014178:Translocation, Genetic
chemical_list: D004268:DNA-Binding Proteins; C072312:ERG protein, human; D015514:Oncogene Proteins, Fusion; D012333:RNA, Messenger; C515553:TMPRSS2-ERG fusion protein, human; D015534:Trans-Activators; D000071230:Transcriptional Regulator ERG